Back to News
Market Impact: 0.3
Verastem (VSTM) Reports Q3 Loss, Misses Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechAnalyst Estimates
Verastem reported a quarterly loss of $0.74 per share, 30 cents wider than the Zacks Consensus Estimate of a $0.44 loss. The loss narrowed from $1.35 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment
VSTM-0.50
More News
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook
- e.l.f. CEO: All of Our Brands Are Growing
- AI data center firm IREN delays Microsoft AI deliveries, plans $15 billion spending push
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Automating Financial Model Updates: A Source-Controlled Workflow
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements